Update on human immunodeficiency virus (HIV)-2 infection
- PMID: 21367732
- PMCID: PMC3106263
- DOI: 10.1093/cid/ciq248
Update on human immunodeficiency virus (HIV)-2 infection
Abstract
Infection with human immunodeficiency virus type 2 (HIV-2) occurs mainly in West Africa, but an increasing number of cases have been recognized in Europe, India, and the United States. In this era of global integration, clinicians must be aware of when to consider the diagnosis of HIV-2 infection and how to test for this virus. Although there is debate regarding when therapy should be initiated and which regimen should be chosen, recent trials have provided important information on treatment options for HIV-2 infection. In this review, we present information on recent clinical advances in our understanding of HIV-2 infection and highlight remaining diagnostic and therapeutic challenges.
Figures
Similar articles
-
Human Immunodeficiency Virus Type 2: The Neglected Threat.Pathogens. 2021 Oct 25;10(11):1377. doi: 10.3390/pathogens10111377. Pathogens. 2021. PMID: 34832533 Free PMC article. Review.
-
Viral response to antiretroviral therapy in a patient coinfected with HIV type 1 and type 2.Clin Infect Dis. 2005 Jul 15;41(2):e19-21. doi: 10.1086/431204. Epub 2005 May 31. Clin Infect Dis. 2005. PMID: 15983906
-
Antiretroviral therapy and drug resistance in human immunodeficiency virus type 2 infection.Antiviral Res. 2014 Feb;102:70-86. doi: 10.1016/j.antiviral.2013.12.001. Epub 2013 Dec 15. Antiviral Res. 2014. PMID: 24345729 Review.
-
First HIV-2 infection in a child in Turkey.J Infect Dev Ctries. 2016 Sep 30;10(9):1042-1044. doi: 10.3855/jidc.7854. J Infect Dev Ctries. 2016. PMID: 27694740 No abstract available.
-
Human immunodeficiency virus type 2 in two Saudi families.Ann Saudi Med. 2011 Jul-Aug;31(4):417-20. doi: 10.4103/0256-4947.76408. Ann Saudi Med. 2011. PMID: 21293067 Free PMC article.
Cited by
-
Efficacy of Integrase Strand Transfer Inhibitors and the Capsid Inhibitor Lenacapavir against HIV-2, and Exploring the Effect of Raltegravir on the Activity of SARS-CoV-2.Viruses. 2024 Oct 13;16(10):1607. doi: 10.3390/v16101607. Viruses. 2024. PMID: 39459940 Free PMC article.
-
A pilot investigation of the association between HIV-1 Vpr amino acid sequence diversity and the tryptophan-kynurenine pathway as a potential mechanism for neurocognitive impairment.Virol J. 2024 Feb 23;21(1):47. doi: 10.1186/s12985-024-02313-1. Virol J. 2024. PMID: 38395987 Free PMC article.
-
Comparative Analysis of Differential Cellular Transcriptome and Proteome Regulation by HIV-1 and HIV-2 Pseudovirions in the Early Phase of Infection.Int J Mol Sci. 2023 Dec 27;25(1):380. doi: 10.3390/ijms25010380. Int J Mol Sci. 2023. PMID: 38203551 Free PMC article.
-
Systematic review and meta-analysis of seroprevalence of human immunodeficiency virus serological markers among pregnant women in Africa, 1984-2020.World J Crit Care Med. 2023 Dec 9;12(5):264-285. doi: 10.5492/wjccm.v12.i5.264. eCollection 2023 Dec 9. World J Crit Care Med. 2023. PMID: 38188451 Free PMC article.
-
Vpr attenuates antiviral immune responses and is critical for full pathogenicity of SIVmac239 in rhesus macaques.iScience. 2023 Oct 26;26(12):108351. doi: 10.1016/j.isci.2023.108351. eCollection 2023 Dec 15. iScience. 2023. PMID: 38025783 Free PMC article.
References
-
- Centers for Disease Control. Factsheet HIV Type 2. Available at: http://wonder.cdc.gov/wonder/prevguid/m0038078/m0038078.asp. Accessed 24 June 2010.
-
- da Silva Z, Oliveira I, Andersen A, et al. Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: is HIV-2 disappearing? AIDS. 2008;22:1195–202. - PubMed
-
- van der Loeff MF, Awasana A, Sarge-Njie R, et al. Sixteen years of HIV surveillance in a West African research clinic reveals divergent epidemic trends of HIV-1 and HIV-2. Int J Epidemiol. 2006;35:1322–28. - PubMed
-
- van Tienen C, van der Loeff MS, Zaman S, et al. Two distinct epidemics: the rise of HIV-1 and decline of HIV-2 infection between 1990 and 2007 in rural Guinea-Bissau. J Acquir Immune Defic Syndr. 2010;53:640–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

